about
A masked NES in INI1/hSNF5 mediates hCRM1-dependent nuclear export: implications for tumorigenesisThe role of opiorphins (endogenous neutral endopeptidase inhibitors) in urogenital smooth muscle biologyProteomics analysis identifies molecular targets related to diabetes mellitus-associated bladder dysfunctionc-MYC interacts with INI1/hSNF5 and requires the SWI/SNF complex for transactivation functionRecruitment of a SAP18-HDAC1 complex into HIV-1 virions and its requirement for viral replicationMolecular targets for diabetes mellitus-associated erectile dysfunction.Nanoparticles as a novel delivery vehicle for therapeutics targeting erectile dysfunction.The opiorphin gene (ProL1) and its homologues function in erectile physiology.Opiorphin is a master regulator of the hypoxic response in corporal smooth muscle cells.The effect of methamphetamine on an animal model of erectile function.Peptides in seminal fluid and their role in infertility: a potential role for opiorphin inhibition of neutral endopeptidase activity as a clinically relevant modulator of sperm motility: a reviewTopically applied NO-releasing nanoparticles can increase intracorporal pressure and elicit spontaneous erections in a rat model of radical prostatectomy.Oxidative stress status accompanying diabetic bladder cystopathy results in the activation of protein degradation pathwaysOpiorphin-dependent upregulation of CD73 (a key enzyme in the adenosine signaling pathway) in corporal smooth muscle cells exposed to hypoxic conditions and in corporal tissue in pre-priapic sickle cell mice.Evidence for a distinct gut microbiome in kidney stone formers compared to non-stone formers.Using gene chips to identify organ-specific, smooth muscle responses to experimental diabetes: potential applications to urological diseases.Variable coding sequence protein A1 as a marker for erectile dysfunctionhSMR3A as a marker for patients with erectile dysfunctionSustained Nitric Oxide-Releasing Nanoparticles Induce Cell Death in Candida albicans Yeast and Hyphal Cells, Preventing Biofilm Formation In Vitro and in a Rodent Central Venous Catheter ModelBasic Science Evidence for the Link Between Erectile Dysfunction and Cardiometabolic Dysfunction.Markers of erectile dysfunction.Testosterone regulates erectile function and Vcsa1 expression in the corpora of rats.Sustained Nitric Oxide-Releasing Nanoparticles Interfere with Methicillin-Resistant Staphylococcus aureus Adhesion and Biofilm Formation in a Rat Central Venous Catheter Model.Translational Perspective on the Role of Testosterone in Sexual Function and DysfunctionLongitudinal studies of time-dependent changes in both bladder and erectile function after streptozotocin-induced diabetes in Fischer 344 male rats.Novel insights into development of diabetic bladder disorder provided by metabolomic analysis of the rat nondiabetic and diabetic detrusor and urothelial layer.Transcription of G-protein coupled receptors in corporeal smooth muscle is regulated by the endogenous neutral endopeptidase inhibitor sialorphin.The mechanism of opiorphin-induced experimental priapism in rats involves activation of the polyamine synthetic pathwayAgeing causes cytoplasmic retention of MaxiK channels in rat corporal smooth muscle cells.Experimental diabetes alters connexin43 derived gap junction permeability in short-term cultures of rat corporeal vascular smooth muscle cells.Experimental priapism is associated with increased oxidative stress and activation of protein degradation pathways in corporal tissue.Intracorporal injection of hSlo cDNA restores erectile capacity in STZ-diabetic F-344 rats in vivo.Urothelial MaxiK-activity regulates mucosal and detrusor metabolism.Smooth-muscle-specific gene transfer with the human maxi-k channel improves erectile function and enhances sexual behavior in atherosclerotic cynomolgus monkeys.Manipulation of the vsg co-transposed region increases expression-site switching in Trypanosoma brucei.hMaxi-K gene transfer in males with erectile dysfunction: results of the first human trial.The successful long-term treatment of age related erectile dysfunction with hSlo cDNA in rats in vivo.Gene therapy in the management of erectile dysfunction (ED): past, present, and future.The role of amino acids in the energy generating pathways of Litomosoides cariniiThe first human trial for gene transfer therapy for the treatment of erectile dysfunction: preliminary results
P50
Q24536149-4A465469-7C9B-4DB7-A3A1-6680D82A0246Q24628822-85FE6F41-E3B9-403A-99B6-F31EEAA3AC21Q24650943-379F2A92-1D61-4340-B41B-A2D7C1BA3C84Q28143677-861EE635-1358-426D-AF21-1CA2574EA36FQ33463283-958B0882-258A-473A-853F-42B27F8E0B17Q33770111-0FB4FC67-A884-43B7-ACF3-F4DEA20D0BD0Q33829654-F4A521CF-BA5E-4EF0-AD43-D3A0E71EAB14Q33857635-EE6FF160-6102-472A-B90C-B39222A56FEBQ33913200-D39F564F-5DF1-446F-BF3C-FE350D3E1861Q34117817-199F3CC9-1363-411E-8B03-84064E78FAE2Q34418060-F13ED42B-B1D9-43E6-AC47-6D8B8C82EE37Q34641767-49E535F9-61FD-4896-98E4-879B117FF226Q35168092-5862A15A-9505-4C4F-BE73-772D852417E0Q35858706-C44AFFD7-45D7-459E-9469-87611D3C6A09Q35999340-31452D10-9D63-4CC9-88A2-1E07D936C50FQ36052371-AEEDEAF1-325C-4800-9514-F1CFCAD5C129Q36082094-4982A5DF-5B8E-40D6-91C4-3E97F1E376BDQ36169362-F99B9705-FAA3-41F2-8099-FCB38D13B8C1Q36730043-ADEB86DD-B357-4686-9F91-0F68897E132FQ36861695-0020CC86-B2C0-4EEE-8EAD-D695AB2D5DE2Q37197791-54EBB224-9524-4620-BB2E-7C5BDC3C2559Q37222126-31988A4E-318B-4773-8B34-FE4758433D50Q37538654-92DBB627-C176-4C1F-8798-2FDFFB2616FBQ38902584-A077AB46-C812-4A58-818A-F79B9D85FF2EQ39882321-B145D63B-0849-4328-91A0-D2635BF11C22Q40982063-4317597B-10FF-4644-AA70-4D1213B9CC4BQ42103710-3332A5A1-05B9-472D-AF71-EB4DF86AC853Q42603490-11CC122F-DFDD-4C39-A88B-F784290FB7A2Q42628321-9F1DB507-6158-41A2-B4C6-3BAE7301C0BEQ42677788-C3D2C3E6-F1B2-4282-8874-CC19A7BB85E2Q42696988-03ED8C41-3CBA-45E2-A26C-7F63833097E8Q45061639-4675E536-27CB-490D-8F20-ED5A7A548F24Q48045336-C19E74F9-DA66-47BF-932D-F9CFB4864F9FQ51661228-4905BDA2-0D01-472E-9258-4AB4341BF887Q52526039-AEB35BBB-3DC8-4909-8CE4-F64992056A16Q53245926-8AFEFA7C-41AC-4609-AFCE-F10826A027B8Q54768731-71C7CB80-B088-4C44-8659-545388B9602AQ55364048-EA82BD72-670B-497A-B4D5-8ECC4550A780Q68349706-97A9B6A7-934A-4F11-BB68-EB76619E4B93Q81865607-A65DA703-BAAB-4605-AE60-BDD752D636F4
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Kelvin P Davies
@ast
Kelvin P Davies
@en
Kelvin P Davies
@es
Kelvin P Davies
@nl
type
label
Kelvin P Davies
@ast
Kelvin P Davies
@en
Kelvin P Davies
@es
Kelvin P Davies
@nl
prefLabel
Kelvin P Davies
@ast
Kelvin P Davies
@en
Kelvin P Davies
@es
Kelvin P Davies
@nl
P106
P1153
7402536142
P31
P496
0000-0002-0201-9210